Single-cell RNA-seq and spatial transcriptomics data of patients with sarcoidosis
Single-cell RNA-seq and spatial transcriptomics data for 12 patients with sarcoidosis. From each patient, we analyzed skin biopsies of both lesional and non-lesional skin and we performed spatial transcriptomics for lesional skin samples. The data are provided as aligned BAM files.
- 41 samples
- DAC: EGAC00001003072
- Technologies: Illumina HiSeq 4000, Illumina NovaSeq 6000
Data Access Agreement (DAA) for controlled access to sequencing data underlying Sarcoidosis baseline samples
1. You, the Data Recipient, agree to only use the Data for the Purpose of the Project. 2. You agree to preserve, at all times, the confidentiality of information and Data pertaining to Data Subjects. You undertake not to use or attempt to use the Data to compromise or otherwise infringe the confidentiality of information on Data Subjects and their right to privacy. 3. You agree not to attempt to identify Data Subjects. 4. You agree that in handling this Data You will follow an up-to-date information technology (IT) policy that must include, at a minimum, the following items: a. Logging and auditing of Access to the Data and to the computer network; b. Password protection to computer network and/or strong data encryption; c. Virus and malware protection to computers on the computer network; d. Secure backup procedure; 5. You acknowledge that Access to the Data is granted for the duration of the Project described in Section I. Any other use of the Data will need to be approved under a new Agreement. 6. You recognize that nothing in this Agreement shall operate to transfer to You any intellectual property rights to the Data. 7. You agree not to make intellectual property claims on the Data and not to use intellectual property protection in ways that would prevent or block Access to, or use of, any element of the Data. 8. You can elect to perform further Research that would add intellectual and resource capital to the Data, and decide to obtain intellectual property rights on these downstream discoveries. In this case, You agree to implement licensing policies that will not obstruct further Research, following the Organisation for Economic Co-operation and Development Guidelines. 9. You agree that the Research Project 1) bears no legal responsibility for the accuracy or comprehensiveness of the Data; 2) accepts no liability for indirect, consequential, or incidental damages or losses arising from use of the Data; and 3) bears no responsibility for the further analysis or interpretation of these Data over and above that published by the Data Controller. 10. You agree to hold the Data Subjects and the Data Controller harmless and to defend and indemnify all these parties against all liabilities, demands, damages, expenses, and losses arising out of Your use for any Purpose of the Data. 11. You agree to a moratorium on publishing global analyses of the dataset until the Data Controller has published their own global analysis or twelve (12) months, the maximum, have passed from the time the Data were deposited, whichever occurs first. You acknowledge that prompt publication or public disclosure of the results of the Research Project is encouraged. 12. You agree to acknowledge the contribution of the Data Controller in all oral and written presentations, disclosures, and Publications resulting from all analyses of the Data. 13. You agree to use the Data in Your group. Any Data Processors shall work under Your direct supervision. You agree to distribute a copy of these terms to the Data Processors. 14. You may not transfer any information included in the Data to anyone unless specifically designated in the Project, or by prior specific or general written authorisation of the Data Controller responsible for the generation of the original Data in each case. 15. You may not transfer the Data itself to anyone outside the Institution, unless the Data Controller has approved such transfer and its terms in writing. 16. Should You wish to share the Data with an external collaborator, the external collaborator must complete a separate Data Access Agreement. 17. You shall ensure that only You and the Data Processors indicated in this document have access to the Data and are bound by the terms of this Agreement. You remain solely and fully responsible for the Data Processor’s potential non-compliance with the provision of the Agreement and/or applicable laws. 18. You accept that this Agreement can be terminated by the Data Controller, for example if the legal status of the Data changes or if parts of this Agreement are violated by the Data Recipient or by the Data Processors. 19. You endeavour to settle any dispute with the Data Controller amicably. If you are unable to reach an Agreement, you will meet and negotiate in good faith in an effort to resolve the issue. If the issue has not been resolved within a reasonable period (e.g. 30 calendar days), you are both entitled to submit it for resolution by an arbitrator. 20. The language of the proceedings will be English if not otherwise agreed. The award of the arbitration will be final and binding upon the parties concerned. 21. This Agreement (and any dispute, controversy, proceedings, or claim of whatever nature arising out of it or its formation) shall be interpreted, governed by and construed in accordance with the laws of Austria, and shall be subject to the exclusive jurisdiction of Austrian courts.
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
Study ID | Study Title | Study Type |
---|---|---|
EGAS00001006970 | Other |
- I added the PubMed ID of the related manuscript.
- Dataset Released
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.